Adomeglivant
CAS No. 1488363-78-5
Adomeglivant( LY-2409021 )
Catalog No. M12058 CAS No. 1488363-78-5
A potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 132 | Get Quote |
|
| 25MG | 213 | Get Quote |
|
| 50MG | 390 | Get Quote |
|
| 100MG | 575 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdomeglivant
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM.
-
DescriptionA potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM; displays >200-fold selectivity over related receptors; exhibits robust glucose-lowering in response to daily oral administration in an ob/ob mouse model of type 2 diabetes mellitus.Diabetes Phase 2 Discontinued.
-
In Vitro——
-
In VivoAnimal Model:Avpires-Cre+ miceDosage:5 mg/kg Administration:Intraperitoneal injection, 30 minutes prior to CNOResult:Completely abolished the hyperglycaemic action of CNO.
-
SynonymsLY-2409021
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGlucagon Receptor
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1488363-78-5
-
Formula Weight555.6277
-
Molecular FormulaC32H36F3NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 5.3 mg/mL
-
SMILESO=C(O)CCNC(C1=CC=C([C@@H](OC2=CC(C)=C(C3=CC=C(C(C)(C)C)C=C3)C(C)=C2)CCC(F)(F)F)C=C1)=O
-
Chemical Nameβ-Alanine, N-[4-[(1S)-1-[[4'-(1,1-dimethylethyl)-2,6-dimethyl[1,1'-biphenyl]-4-yl]oxy]-4,4,4-trifluorobutyl]benzoyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
GLP-1 receptor agoni...
1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.
-
des-His1-[Glu9]-Gluc...
Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitro. Blocks added glucagon-induced hyperglycemia in normal rabbits without affecting glycogenolysis in vivo. Also blocks endogenous glucagon-induced hyperglycemia in streptozocin diabetic rats.
-
Bay 55-9837
Selective VPAC2 receptor agonist (EC50 values are 0.4, 100 and >1000 nM for VPAC2, VPAC1 and PAC1, respectively in a cAMP accumulation assay; IC50 values are 60, 8700 and >10000 nM for VPAC2, VPAC1 and PAC1, respectively in a competition binding assay). Stimulates glucose-dependent insulin secretion in isolated human pancreatic islets. Reduces HIV-1 viral replication and shows cooperative effects when given in conjunction with VPAC1 agonists.
Cart
sales@molnova.com